Table 4

Per cent of first-time responders* with a ≥5-point improvement in the total HIT-6 score

Per cent of patients with a ≥5-point improvement from baseline in the total HIT-6 scoreOnabotulinumtoxinA (n=688)
Treatment cycle 1Treatment cycle 2Treatment cycle 3
387 (56.3)100 (14.5)53 (7.7)
  • *First-time responders for a given time point are patients who never responded at any previous time points.

  • HIT, Headache Impact Test.